Meeder Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-255
Closed -$5K 847
2022
Q3
$5K Buy
255
+115
+82% +$2.52K ﹤0.01% 1535
2022
Q2
$3K Buy
140
+14
+11% +$287 ﹤0.01% 1772
2022
Q1
$3K Buy
+126
New +$2.86K ﹤0.01% 1913
2021
Q4
Sell
-150
Closed -$4K 1189
2021
Q3
$4K Buy
150
+1
+0.7% +$27 ﹤0.01% 1972
2021
Q2
$4K Buy
149
+1
+0.7% +$24 ﹤0.01% 1990
2021
Q1
$3K Hold
148
﹤0.01% 1958
2020
Q4
$2K Hold
148
﹤0.01% 1450
2020
Q3
$2K Hold
148
﹤0.01% 1799
2020
Q2
$2K Sell
148
-5,463
-97% -$56.3K ﹤0.01% 1740
2020
Q1
$58K Buy
5,611
+1,205
+27% +$15.1K ﹤0.01% 867
2019
Q4
$71K Sell
4,406
-14,503
-77% -$221K ﹤0.01% 905
2019
Q3
$349K Buy
18,909
+17,780
+1,575% +$348K 0.02% 475
2019
Q2
$22K Buy
1,129
+1,112
+6,541% +$22.6K ﹤0.01% 1196
2019
Q1
$0 Buy
+17
New +$369 ﹤0.01% 1693
2018
Q4
Sell
-6,529
Closed -$142K 1702
2018
Q3
$142K Buy
6,529
+5,742
+730% +$128K 0.01% 562
2018
Q2
$17.5K Sell
787
-175
-18% -$3.58K ﹤0.01% 996
2018
Q1
$17K Sell
962
-241
-20% -$4.02K ﹤0.01% 923
2017
Q4
$20K Buy
1,203
+777
+182% +$13.3K ﹤0.01% 922
2017
Q3
$7K Buy
426
+50
+13% +$840 ﹤0.01% 1152
2017
Q2
$6K Buy
+376
New +$5.94K ﹤0.01% 1131

Other funds holding ANGO

Meeder Asset Management's ANGO Position: Q4 2022 in Review

Meeder Asset Management sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 255 shares — an estimated $5K sold.

Meeder Asset Management first reported a position in ANGO in Q2 2017 and held it in 20 quarters. The position peaked at $349K in Q3 2019. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

  • Meeder Asset Management reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 255 AngioDynamics shares in Q4 2022, an estimated $5K.
  • Meeder Asset Management first reported a position in AngioDynamics in Q2 2017 and held it in 20 quarters.
  • Meeder Asset Management's AngioDynamics position peaked at $349K in Q3 2019.
  • 149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.